HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH REDUCED TOXICITY CONDITIONING REGIMEN IN MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME (MNGIE)
Gülcihan Özek(Ege University), Savaş Kansoy(Ege University), Zuhal Siviş(University of Michigan), Bridget E. Bax(St George's, University of London), Mediha Akcan(Ege University), Serap Aksoylar(Ege University), Yeşim Oymak(Ege University), Havva Yazıcı(Ege University), Sema Kalkan Uçar(Ege University), Fatma Derya Bulut(Cukurova University), Ebru Canda(Ege University), Merve Yoldaş Çelik(Ege University), Mahmut Çöker(Ege University), Fehime Erdem(Ege University), Özgür Cartı(University of Michigan)
Cited by 0
Related Papers
A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency
|New England Journal of Medicine|2015|244
Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults
|Blood|2020|166
Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency
|Journal of Allergy and Clinical Immunology|2015|141
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Position paper on diagnosis, prognosis, and treatment by the<scp>MNGIE</scp>International Network
|Journal of Inherited Metabolic Disease|2020|86